Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Colorectal cancer screening

J H Bond1

  • 1Gastroenterology Section (111D), Veterans Affairs Medical Center, Minneapolis, MN 55417, USA.

Current Opinion in Oncology
|November 4, 1998
PubMed
Summary
This summary is machine-generated.

Updated colorectal cancer screening guidelines recommend annual fecal occult blood tests and flexible sigmoidoscopy every 5 years for average-risk adults over 50. Research continues to refine detection methods and improve screening compliance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for severe delayed postpolypectomy bleeding.

Endoscopy·2008
Same author

FOBT is not an effective way to screen for gastric cancer.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2007
Same author

Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group.

Gut·2005
Same author

Colon polyps and cancer.

Endoscopy·2005
Same author

Update on colorectal polyps: management and follow-up surveillance.

Endoscopy·2003
Same author

Colon polyps and cancer.

Endoscopy·2003
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Preventive Medicine
  • Oncology

Background:

  • Comprehensive evidence-based guidelines for colorectal cancer screening and surveillance were established in 1997.
  • Recent controlled trials and case-control studies provide compelling scientific data supporting updated recommendations.

Purpose of the Study:

  • To present updated evidence-based guidelines for colorectal cancer screening and surveillance.
  • To incorporate findings from recent studies on screening test efficacy and compliance.
  • To explore emerging screening technologies.

Main Methods:

  • Review of recently completed controlled trials and case-control studies.
  • Analysis of data on the detection of early cancer and polyps by screening tests.
  • Assessment of factors influencing patient compliance with screening recommendations.

Related Experiment Videos

Main Results:

  • Annual fecal occult blood test screening is recommended.
  • Periodic flexible sigmoidoscopy every 5 years is advised for asymptomatic, average-risk individuals over 50.
  • New screening methods are under preliminary investigation.

Conclusions:

  • Updated guidelines incorporate robust scientific evidence for colorectal cancer screening.
  • Emphasis on annual fecal occult blood tests and periodic flexible sigmoidoscopy for early detection.
  • Future screening technologies hold promise for improved clinical feasibility.